Developmental Toxicology Services

About Toxys

Toxys is a privately held biotechnology company offering specialized in vitro toxicology testing services, primarily to pharmaceutical, chemical, and consumer goods companies. Its technology platform is built on unique, stem cell-based reporter assays like ToxTracker (for genotoxicity) and ReproTracker (for developmental toxicity), which provide mechanistic understanding of compound hazards. The company operates a service-based business model, generating revenue by helping clients screen and de-risk compounds early in development. Its value proposition lies in offering human-relevant data that predicts regulatory outcomes and supports the global shift toward New Approach Methodologies (NAMs).

Therapeutic Areas